Learn about recent Benicar® lawsuits by reaching out to a bad drug lawyer at the Hollis Law Firm today.
In 2002, Japanese drugmaker, Daiichi Sankyo, Inc., created a solution for patients suffering from high blood pressure. With the promise of lowering patients’ blood pressure with treatable side effects, the U.S. Food and Drug Administration (FDA) allowed the Japanese drugmaker to release the drug for use in the United States. In the first decade Benicar® was on the market, 11 million prescriptions a year were written for the drug which brought major profits for Daiichi Sankyo, Inc.
Although Benicar became a popular choice among those suffering from hypertension, some patients reported experiencing severe gastrointestinal side effects from Benicar’s active ingredient. Olmesartan medoxomil is the active ingredient found in Benicar that actively dilates the patient’s blood vessels. Benicar causes sprue-like enteropathy, malnourishment, and symptoms that mimic Celiac disease. Patients that are experiencing gastrointestinal side effects are looking into Benicar lawsuits to help determine if their situation constitutes a viable claim against Benicar’s manufacturer.
How will researching Benicar lawsuits help me if I think my case may qualify for compensation?
Patients who are researching Benicar lawsuits are comparing their case to other patients’ cases. Every case is different. It is important to seek a harmful drug lawyer to help determine if your unique case qualifies you for compensation. The Hollis Law Firm has experience in helping those who have fallen victim to bad drugs. It is easy to contact a member of the Hollis Law Firm by calling toll-free at 1-800-701-3672 or filling out the form found on this page. Please note that this initial consultation does not constitute an official attorney client relationship.